Agenerase har i kombination med andre antivirale lægemidler, men uden ritonavir, været genstand for to hovedundersøgelser af 736 voksne, der var inficeret med hiv og ikke tidligere var blevet behandlet med proteasehæmmere.
Agenerase, in combination with other antiviral medicines but without ritonavir, has been studied in two main studies including 736 HIV-infected adults who had not previously been treated with protease inhibitors.